Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$1.62 - $2.04 $15,169 - $19,102
-9,364 Reduced 62.6%
5,594 $9,000
Q1 2024

Apr 25, 2024

BUY
$1.66 - $2.42 $24,830 - $36,198
14,958 New
14,958 $28,000
Q3 2023

Nov 01, 2023

SELL
$1.5 - $3.07 $9,505 - $19,454
-6,337 Reduced 62.61%
3,785 $6,000
Q2 2023

Aug 04, 2023

BUY
$1.79 - $2.9 $6,512 - $10,550
3,638 Added 56.11%
10,122 $24,000
Q1 2023

Apr 27, 2023

SELL
$2.65 - $3.81 $66,621 - $95,783
-25,140 Reduced 79.5%
6,484 $19,000
Q4 2022

Feb 02, 2023

BUY
$3.38 - $4.22 $11,194 - $13,976
3,312 Added 11.7%
31,624 $115,000
Q3 2022

Nov 04, 2022

BUY
$3.43 - $5.83 $62,484 - $106,205
18,217 Added 180.46%
28,312 $101,000
Q2 2022

Aug 03, 2022

BUY
$4.41 - $5.69 $26,799 - $34,578
6,077 Added 151.24%
10,095 $53,000
Q1 2022

May 02, 2022

SELL
$4.81 - $6.99 $67,883 - $98,649
-14,113 Reduced 77.84%
4,018 $22,000
Q4 2021

Feb 23, 2022

SELL
$5.97 - $7.93 $54,565 - $72,480
-9,140 Reduced 33.52%
18,131 $123,000
Q2 2021

Aug 12, 2021

BUY
$5.35 - $6.35 $16,156 - $19,177
3,020 Added 12.45%
27,271 $161,000
Q1 2021

Apr 26, 2021

BUY
$5.68 - $7.87 $26,252 - $36,375
4,622 Added 23.55%
24,251 $145,000
Q4 2020

Feb 02, 2021

SELL
$5.25 - $8.56 $44,546 - $72,631
-8,485 Reduced 30.18%
19,629 $135,000
Q3 2020

Oct 14, 2020

BUY
$5.78 - $7.47 $71,839 - $92,844
12,429 Added 79.24%
28,114 $175,000
Q2 2020

Jul 13, 2020

SELL
$4.5 - $7.02 $224,775 - $350,649
-49,950 Reduced 76.1%
15,685 $103,000
Q1 2020

Apr 29, 2020

BUY
$2.87 - $5.49 $172,420 - $329,822
60,077 Added 1080.91%
65,635 $305,000
Q4 2019

Feb 05, 2020

BUY
$3.84 - $4.86 $21,342 - $27,011
5,558 New
5,558 $23,000
Q3 2019

Oct 15, 2019

SELL
$4.86 - $6.05 $35,735 - $44,485
-7,353 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$4.51 - $6.6 $33,162 - $48,529
7,353 New
7,353 $41,000
Q4 2018

Jan 16, 2019

SELL
$4.89 - $7.16 $27,623 - $40,446
-5,649 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$6.89 - $7.78 $38,921 - $43,949
5,649 New
5,649 $40,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $319M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.